Loading clinical trials...
Loading clinical trials...
This study will be conducted without blind method. The portable seat device devised to maintain lumbar lordosis will be made within 1 year after the loss of ambulation in the participants with Duchenn...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seoul National University Hospital
NCT06817382 · Duchenne Muscular Dystrophy
NCT06839469 · Spinal Muscular Atrophy Type 3, Duchenne Muscular Dystrophy (DMD)
NCT07037862 · Duchenne Muscular Dystrophy (DMD)
NCT07160634 · Duchenne Muscular Dystrophy
NCT06450639 · Duchenne Muscular Dystrophy
Seoul National University
Seoul
Seoul National University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions